Enoxaparin Dose Requirements to Achieve Therapeutic Low-molecular-weight Heparin Anti-factor Xa Levels in Infants and Young Children.

Wysocki, Emma L; Kuhn, Alexis; Steinbrenner, Jenny; Tyrrell, Laura; Abdel-Rasoul, Mahmoud; Dunn, Amy; Cloyd, Colleen

Wysocki, Emma L; Kuhn, Alexis; Steinbrenner, Jenny; Tyrrell, Laura; Abdel-Rasoul, Mahmoud; Dunn, Amy; Cloyd, Colleen.

Afiliação

Wysocki EL; Departments of Pharmacy.
Kuhn A; Mayo Clinic, Rochester, MN.
Steinbrenner J; Departments of Pharmacy.
Tyrrell L; Pediatric Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital.
Abdel-Rasoul M; Department of Biomedical Informatics, Center for Biostatistics, College of Medicine, The Ohio State University, Columbus, OH.
Dunn A; Pediatric Hematology, Oncology and Bone Marrow Transplant, Nationwide Children's Hospital.
Cloyd C; Departments of Pharmacy.

J Pediatr Hematol Oncol ; 43(7): e946-e950, 2021 Oct 01.

Article em En | MEDLINE | ID: mdl-33512867

Assuntos

Anticoagulantes/administração & dosagem; Enoxaparina/administração & dosagem; Inibidores do Fator Xa/sangue; Heparina de Baixo Peso Molecular/sangue; Trombose/tratamento farmacológico; Pré-Escolar; Fator Xa/química; Feminino; Seguimentos; Humanos; Lactente; Masculino; Prognóstico; Estudos Retrospectivos; Trombose/sangue; Trombose/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Enoxaparina / Heparina de Baixo Peso Molecular / Inibidores do Fator Xa / Anticoagulantes Tipo de estudo: Observational_studies / Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google